Send enough information to define the configuration
An injection pen RFQ should state the supply boundary, container, dose requirements, target market, quantities and required evidence. Identify unknown inputs explicitly so the supplier can return assumptions and deviations with its quotation.
An effective request for quotation starts with the delivery problem, not a photograph alone. Describe the intended drug presentation, administration route, primary container and dose requirements. Include the intended users and market, the project stage and whether you need an existing configuration or custom development. If confidentiality limits what can be shared, state the information category and arrange an appropriate disclosure process before sending proprietary formulation details. Provide a drawing reference when available and identify which dimensions or requirements are fixed. A dose range should be accompanied by the proposed increment and any relevant volume assumptions. List unknowns explicitly. This lets the supplier respond with questions and a scope rather than guessing a standard product that may not fit the eventual application or commercial plan.
Request a response that can be compared
An RFQ is ready for comparison when every supplier responds against the same baseline and identifies exclusions. Record technical deviations, sample purpose, commercial terms and unresolved responsibilities before selecting a proposal.
Ask suppliers to respond in a structured way: proposed configuration, deviations, evidence available, work still needed, commercial scope and schedule assumptions. Include sample purpose, expected quantity and the documents required for your internal review. Distinguish a quotation request from an instruction to manufacture or ship a device for clinical use. Specify who will own the final product labeling, market submission and quality agreement. For a distributor inquiry, also explain the intended territory and whether supply is device-only or part of an existing authorized product arrangement. Keep a record of each open question and its owner. A complete first response may still contain unresolved technical items; what matters is that they are visible and can be closed through an agreed review rather than buried inside a generic sales proposal.
Parameters & review checklist
- Use, users and target market
- Container and dose specification
- Quantity, stage and customization
- Required evidence and responsibility matrix
RFQ response acceptance checklist
| Item | Buyer request | Supplier response expected |
|---|---|---|
| Supply boundary | State exactly what will be purchased | Confirm included activities and exclusions |
| Configuration | Identify container and dose requirements | Name baseline revisions and deviations |
| Samples | Separate appearance and engineering purposes | State sample purpose and evidence delivered |
| Commercial | Separate pilot and production quantities | Provide written quantity, terms and lead-time basis |
Apply this guide to your project
Use these configuration briefs to record the requirements discussed above, then prepare the document and quotation requests for your project.
Platform comparison and downloadable buyer worksheets ↗
Sample references and supplier evidence checklist ↗
Common questions
Can I inquire before the formulation is finalized?
Yes. Identify provisional parameters and open decisions so the discussion is clearly scoped as feasibility work.
Continue exploring
Buyer decision tools
How should I add a medicine name to an injector pen RFQ?
Add the molecule and intended market together with the exact formulation, concentration and presentation requirements. For tirzepatide and liraglutide, presentation and setting distinctions need explicit fields rather than a generic request for a peptide pen.
Name the source reference only as context and state which attributes the proposed project actually requires. Record the container drawing and revision, dose-setting scheme, sample purpose and the entities responsible for filling, verification and release. Mark unknown fields as unresolved instead of importing numbers from another product. Ask suppliers to return a proposed baseline, exceptions and the evidence route. Use the focused guides to supplement the RFQ template with molecule-specific questions; the result should define the next review decision, not imply supply of a named original medicine.